126 related articles for article (PubMed ID: 15283154)
1. [Resistance to target-based therapy and its circumvention].
Nishio K
Nihon Rinsho; 2004 Jul; 62(7):1343-7. PubMed ID: 15283154
[TBL] [Abstract][Full Text] [Related]
2. [Problems in the current target therapy of malignancies].
Stukov AN; Gershanovich ML; Filov VA; Imianitov EN
Vopr Onkol; 2005; 51(5):607-11. PubMed ID: 16756022
[No Abstract] [Full Text] [Related]
3. [Molecular target therapy for malignant tumors].
Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():76-80. PubMed ID: 15796061
[No Abstract] [Full Text] [Related]
4. Reversing resistance to targeted therapy.
Vidal L; Attard G; Kaye S; De Bono J
J Chemother; 2004 Nov; 16 Suppl 4():7-12. PubMed ID: 15688600
[TBL] [Abstract][Full Text] [Related]
5. [Molecular targeted therapy].
Stenner-Liewen F; Zippelius A; Pestalozzi BC; Knuth A
Chirurg; 2006 Dec; 77(12):1118-25. PubMed ID: 17109101
[TBL] [Abstract][Full Text] [Related]
6. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.
Becker JC; Muller-Tidow C; Serve H; Domschke W; Pohle T
World J Gastroenterol; 2006 Jun; 12(21):3297-305. PubMed ID: 16733844
[TBL] [Abstract][Full Text] [Related]
7. The era of personalized medicine: back to basics.
Hutchinson L; DeVita VT
Nat Clin Pract Oncol; 2008 Nov; 5(11):623. PubMed ID: 18957968
[No Abstract] [Full Text] [Related]
8. [Antineoplastic agents targeting tyrosine kinases].
Guren TK; Christoffersen T; Thoresen GH; Wisløff F; Dajani O; Tveit KM
Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3115-9. PubMed ID: 16299568
[TBL] [Abstract][Full Text] [Related]
9. [The mechanisms of the resistance to molecular targeting agents].
Akiyama S
Nihon Rinsho; 2004 Jul; 62(7):1297-304. PubMed ID: 15283147
[TBL] [Abstract][Full Text] [Related]
10. [Molecular targeted therapy for malignant brain tumors].
Okamura T; Kurisu K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():520-6. PubMed ID: 16201575
[No Abstract] [Full Text] [Related]
11. Autophagy facilitates the EGFR-TKI acquired resistance of non-small-cell lung cancer cells.
Liu D; Yang Y; Zhao S
J Formos Med Assoc; 2014 Mar; 113(3):141-2. PubMed ID: 24630031
[No Abstract] [Full Text] [Related]
12. Lung cancer: not just for smokers. People who never smoked may have a different form of the disease that responds better to a new generation of targeted medications.
Harv Health Lett; 2007 Jan; 32(3):4-5. PubMed ID: 17323498
[No Abstract] [Full Text] [Related]
13. Recent advances of molecular targeted agents: opportunities for imaging.
Dancey JE
Cancer Biol Ther; 2003; 2(6):601-9. PubMed ID: 14688462
[TBL] [Abstract][Full Text] [Related]
14. Researchers optimistic about sea change in cancer treatment.
Stephenson J
JAMA; 2001 Jun; 285(22):2841-2. PubMed ID: 11401587
[No Abstract] [Full Text] [Related]
15. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
Kim R; Toge T
Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
[TBL] [Abstract][Full Text] [Related]
16. Added value of molecular targeted agents in oncology.
Soria JC; Blay JY; Spano JP; Pivot X; Coscas Y; Khayat D
Ann Oncol; 2011 Aug; 22(8):1703-16. PubMed ID: 21300696
[TBL] [Abstract][Full Text] [Related]
17. Dissecting kinase signaling pathways.
Boyle SN; Koleske AJ
Drug Discov Today; 2007 Sep; 12(17-18):717-24. PubMed ID: 17826684
[TBL] [Abstract][Full Text] [Related]
18. [Molecular targets in colon cancer].
Borner MM
Ther Umsch; 2006 Apr; 63(4):243-8. PubMed ID: 16689454
[TBL] [Abstract][Full Text] [Related]
19. [Molecular targeting therapy of hematopoietic tumors].
Matsumura I; Kanakura Y
Nihon Naika Gakkai Zasshi; 2006 Jul; 95(7):1375-81. PubMed ID: 16893036
[No Abstract] [Full Text] [Related]
20. Targeted therapies for the treatment of cancer.
Kim JA
Am J Surg; 2003 Sep; 186(3):264-8. PubMed ID: 12946830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
